Annual report pursuant to Section 13 and 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.24.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]    
Revenues $ 16,296,958 $ 39,354,352
FC2 [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 16,283,945 39,351,937
FC2, U.S. Prescription Channel [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 5,823,921 30,223,079
FC2, Global Public Health Sector [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 10,460,024 9,128,858
Other [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 13,013 $ 2,415